AI in Primary Diagnosis: From FDA Clearance to Application in Real-World Settings (USCAP 2025)

In this USCAP 2025 symposium, Dr. Mahul Amin (LabCorp, Univ. of TN), Dr. Harshwardhan Thaker (UTMB) and Mariano de Socarraz (CorePlus) will provide an overview of the role AI is currently playing in the primary diagnosis of prostate cancer. New data will be presented from robust precision and clinical validation studies conducted at multiple US and European laboratories as part of the FDA clearance, demonstrating AI’s clinical utility and benefits compared with the current standard of care. Presenters will also share their digital pathology journeys and the benefits they are seeing from implementing AI-powered tools into routine clinical workflows in both private reference laboratories and academic medical centers.

Share this article:

Subscribe to our newsletter:

By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?
How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News
The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics
Scroll to Top
IBEX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.